Contineum Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Contineum Therapeutics, Inc.
CIK #0001855175
EDGAR Form CIK 2011 - 2025
10-K [0001855175]
10-Q [0001855175]
3 [0001855175]
4 [0001855175]
8-K [0001855175]
SC 13G [0001855175]
Form 13D/13G Filer Form 13D/13G Subject Filed
RA Capital Management LP Contineum Therapeutics Inc [2025-07-25]
Sectoral Asset Management Inc Contineum Therapeutics Inc [2024-11-14]
Franklin Resources Inc Contineum Therapeutics Inc [2024-10-31]
Perceptive Advisors LLC Contineum Therapeutics Inc [2024-04-15]
Suvretta Capital Management LLC Contineum Therapeutics Inc [2024-04-15]
Johnson & Johnson Contineum Therapeutics Inc [2024-04-10]
Form 3/4/5 Subject 2011 - 2025
Contineum Therapeutics, Inc.
Miralles Gines Diego
Boyce Sarah
Schimmelpennink Evert B.
Brady Todd R.
Ignelzi Troy A.
Lyons-Williams Lori
Ware Olivia C
Watkins Tim
Stengone Carmine N.
Healy John Stephen
Slover Peter T
Lorrain Daniel S.
Huhn Stephen L.
Versant Vantage I GP-GP, LLC
Versant Venture Capital IV, L.P.
Versant Venture Capital VI, L.P.
Versant Ventures VI GP, L.P.
Versant Side Fund IV, L.P.
Versant Ventures VI GP-GP, LLC
Versant Ventures IV, LLC
Versant Vantage I GP, L.P.
Versant Vantage I, L.P.
Johnson & Johnson
Johnson & Johnson Innovation - JJDC, Inc.
Terms | Privacy | Guide
tony@aum13f.com